PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
59.87
Similar ESG score to FBIO's 61.95. Bruce Berkowitz would investigate if industry ESG norms adequately address regulatory risks.
50.00
Environmental score 1.1-1.2x FBIO's 42.38. Guy Spier would verify if superior environmental practices translate to better regulatory positioning.
61.14
Social score 80-90% of FBIO's 71.55. Walter Schloss would scrutinize stakeholder relations and reputational exposure.
68.48
Similar governance score to FBIO's 71.93. Bruce Berkowitz would investigate if industry governance norms adequately protect shareholder value.